Biotechnology Companies By One Year Return

One Year Return
One Year ReturnEfficiencyMarket RiskExp Return
1DRUG Bright Minds Biosciences
3.08 K
(0.01)
 5.13 
(0.06)
2RGC Regencell Bioscience Holdings
1.13 K
 0.19 
 33.33 
 6.34 
3MNPR Monopar Therapeutics
921.2
 0.12 
 8.26 
 0.99 
4CMRX Chimerix
759.6
 0.20 
 9.73 
 1.97 
5NTRBW Nutriband Warrant
479.67
 0.10 
 25.47 
 2.67 
6CADL Candel Therapeutics
451.68
 0.00 
 6.38 
 0.03 
7SMMT Summit Therapeutics PLC
441.18
 0.04 
 5.45 
 0.23 
8XCUR Exicure
325.32
 0.02 
 11.72 
 0.24 
9IBIO iBio, Common Stock
283.48
 0.17 
 7.10 
 1.24 
10MESO Mesoblast
259.03
(0.08)
 4.54 
(0.35)
11ADMA ADMA Biologics
211.08
 0.08 
 3.33 
 0.26 
12BNTC Benitec Biopharma Ltd
195.77
 0.09 
 4.73 
 0.44 
13INSM Insmed Inc
190.67
 0.09 
 2.22 
 0.20 
14TVTX Travere Therapeutics
177.54
 0.09 
 3.92 
 0.35 
15TGTX TG Therapeutics
177.2
 0.12 
 3.95 
 0.48 
16QURE Uniqure NV
169.92
(0.04)
 5.24 
(0.21)
17XGN Exagen Inc
150.65
(0.01)
 8.29 
(0.12)
18ALDX Aldeyra
128.77
 0.12 
 4.66 
 0.57 
19GRAL GRAIL, LLC
128.4
 0.13 
 9.49 
 1.21 
20EBS Emergent Biosolutions
125.41
(0.11)
 4.67 
(0.53)
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
One Year Return is the annualized return generated from holding a security for exactly 12 months. The measure is considered to be good short-term measures of fund performance. In other words, it represents the capital appreciation of fund investments over the last year. However when the market is volatile such as in recent years, One Year Return measure can be misleading. Although One Year Fund Return indicator can give a sense of overall fund short-term potential, it is recommended to look at mid and long term return measure before selecting a particular fund or ETF. The great way to validate fund short-term performance is to compare it with other similar funds or ETFs for the same 12 months interval.